Price of monogravir capsules (molnupiravir)

Molnupiravir capsules (Molnupiravir) is a new drug used to treat COVID-19. It was developed in response to the global pandemic of the new coronavirus (SARS-CoV-2) to provide an oral medication to alleviate symptoms and reduce the spread of the virus.

Monolavir capsules are already on the market in China, but are not yet included in medical insurance. Please consult your local hospital pharmacy for specific prices. The cheaper ones abroad are Indian generic drugs, which cost around three to four hundred yuan, and the ingredients of domestic original drugs and foreign generic drugs are basically the same.

Monoravir’s mechanism of action is very unique. It is a nucleoside analog that can interfere with the viralRNAreplication process, thereby preventing the growth and replication of the virus. This interference prevents the virus from effectively multiplying within host cells, thereby reducing the symptoms and infectivity of COVID-19.

This drug is being studied to provide more treatment options for patients infected with COVID-19, especially in the early stages of infection, and to reduce the risk of hospitalization and death. One of the biggest advantages of monogravir capsules is that it is an oral formulation that patients can use at home without the need for hospitalization.

However, it is important to note that monogravir capsules are still being studied and evaluated, including for safety and effectiveness. In addition, some side effects such as nausea, vomiting, diarrhea, etc. have been observed. Therefore, patients should follow the advice of their medical professional before using monogravir capsules, especially if potential risk factors are present.

In short, monogravir capsules, as an oral medication, are expected to provide a new treatment option and help alleviate the impact of the epidemic, but patients should always consult their doctor when using it to ensure safe and effective use.